Abramson Cancer Center at Penn Medicine: Ovarian Neoplasms trials

The registry lists 11 Ovarian Neoplasms studies with Abramson Cancer Center at Penn Medicine as lead sponsor. 2 are open to participants now and 1 have results posted.

Early Phase 1 1Phase 1 2Phase 2 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Clinician Nudge to Referral of Adnexal Masses to Gynecologic OncologyEnrolling by invitationNCT07078409Not applicable
• Healthy Volunteers StudyRecruitingNCT06962059
• Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With CancerCompletedNCT01037790Phase 2Results posted
• Nudge to Gynecologic OncologyActive, not recruitingNCT06451263Not applicable
• Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian CancerActive, not recruitingNCT06436248
• Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer PredispositionCompletedNCT05721326Not applicable
• OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian CancerWithdrawnNCT04941378Phase 1
• Physician-Patient Communication and Expectations Regarding Ovarian Cancer PrognosisTerminatedNCT02769546
• WISER After Ovarian Cancer - Exercise Pilot StudyCompletedNCT02529150Not applicable
• Autologous OC-L Vaccine and Ovarian CancerTerminatedNCT02452775Phase 1
• Autologous OC-DC Vaccine in Ovarian CancerCompletedNCT01132014Early Phase 1